NewsStay Updated with the Latest News from 3billion.
3billion receives accreditation from the College of American Pathologists
3billion selected as a finalist of the Novartis Korea’s Health X-Challenge Seoul
International Case Reviews with Kuala Lumpur Hospital
3billion announces pathogenicity predictor ‘3Cnet’
3billion looks to 2022 IPO, expansion into drug discovery
Rare disease screening firm 3Billion closes $13M Series C financing